QIAGEN powered by
5 Ways HSMD Helps Researchers in the Fight Against Cancer

QIAGEN Digital Insights Friday, September 30, 2022

In oncology research, identifying potentially actionable gene alterations and exploiting cancer’s molecular vulnerabilities is becoming increasingly difficult. Due to the…

Prioritize biologically- and clinically-relevant mutations in your NGS cancer data

QIAGEN Digital Insights Monday, August 15, 2022

Many labs struggle with prioritizing clinically- and biologically-relevant variants among the millions of variants detected using NGS. Labs are starting…